BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38326640)

  • 1. Repaglinide restrains HCC development and progression by targeting FOXO3/lumican/p53 axis.
    Tan Y; Zhou Y; Zhang W; Wu Z; Xu Q; Wu Q; Yang J; Lv T; Yan L; Luo H; Shi Y; Yang J
    Cell Oncol (Dordr); 2024 Feb; ():. PubMed ID: 38326640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells.
    Salcher S; Spoden G; Huber JM; Golderer G; Lindner H; Ausserlechner MJ; Kiechl-Kohlendorfer U; Geiger K; Obexer P
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA PRR34-AS1 Aggravates the Progression of Hepatocellular Carcinoma by Adsorbing microRNA-498 and Thereby Upregulating FOXO3.
    Liu Z; Li Z; Xu B; Yao H; Qi S; Tai J
    Cancer Manag Res; 2020; 12():10749-10762. PubMed ID: 33154667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA LINC01124 activates hepatocellular carcinoma cell proliferation, migration, and invasion by absorbing microRNA-1247-5p and overexpressing FOXO3.
    Sun L; Zhang Y; Yao Y; DU H; Zhang Y; Fang A
    Oncol Res; 2021; 29(3):175-187. PubMed ID: 37304672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits hepatocellular carcinoma development by inducing apoptosis and pyroptosis through regulating FOXO3.
    Shen Z; Zhou H; Li A; Wu T; Ji X; Guo L; Zhu X; Zhang D; He X
    Aging (Albany NY); 2021 Sep; 13(18):22120-22133. PubMed ID: 34546972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway.
    Zhou C; Liu C; Liu W; Chen W; Yin Y; Li CW; Hsu JL; Sun J; Zhou Q; Li H; Hu B; Fu P; Atyah M; Ma Q; Xu Y; Dong Q; Hung MC; Ren N
    Theranostics; 2020; 10(10):4627-4643. PubMed ID: 32292519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LukS-PV inhibits the proliferation of hepatocellular carcinoma cells by maintaining FOXO3 stability via the PI3K/AKT signaling pathway.
    Nie Z; Shi L; Song K; Xu X; Ding P; Lu B; Wu G; Ma X
    Cell Signal; 2022 Jul; 95():110357. PubMed ID: 35589047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway.
    Shi R; Liu Z
    Cancer Cell Int; 2022 Apr; 22(1):150. PubMed ID: 35410346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct activation of forkhead box O3 by tumor suppressors p53 and p73 is disrupted during liver regeneration in mice.
    Kurinna S; Stratton SA; Tsai WW; Akdemir KC; Gu W; Singh P; Goode T; Darlington GJ; Barton MC
    Hepatology; 2010 Sep; 52(3):1023-32. PubMed ID: 20564353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
    Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
    Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZEB1 Transcriptionally Activates PHGDH to Facilitate Carcinogenesis and Progression of HCC.
    Wang H; Lin F; Xu Z; Yu S; Li G; Liao S; Zhao W; Zhang F; Wang J; Wang S; Ouyang C; Zhang C; Xia H; Wu Y; Jiang B; Li Q
    Cell Mol Gastroenterol Hepatol; 2023; 16(4):541-556. PubMed ID: 37331567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway.
    Liu W; Li X; Chu ES; Go MY; Xu L; Zhao G; Li L; Dai N; Si J; Tao Q; Sung JJ; Yu J
    Hepatology; 2011 Mar; 53(3):843-53. PubMed ID: 21319196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZNF498 promotes hepatocellular carcinogenesis by suppressing p53-mediated apoptosis and ferroptosis via the attenuation of p53 Ser46 phosphorylation.
    Zhang X; Zheng Q; Yue X; Yuan Z; Ling J; Yuan Y; Liang Y; Sun A; Liu Y; Li H; Xu K; He F; Wang J; Wu J; Zhao C; Tian C
    J Exp Clin Cancer Res; 2022 Feb; 41(1):79. PubMed ID: 35227287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO3-induced lncRNA LOC554202 contributes to hepatocellular carcinoma progression via the miR-485-5p/BSG axis.
    Yang L; Deng WL; Zhao BG; Xu Y; Wang XW; Fang Y; Xiao HJ
    Cancer Gene Ther; 2022 Mar; 29(3-4):326-340. PubMed ID: 33654226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of FOXO3 is associated with poor prognosis in patients with hepatocellular carcinoma.
    Song SS; Ying JF; Zhang YN; Pan HY; He XL; Hu ZM; Wang HJ; Dou XB; Mou XZ
    Oncol Lett; 2020 Apr; 19(4):3181-3188. PubMed ID: 32256814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
    Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
    J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDX56 transcriptionally activates MIST1 to facilitate tumorigenesis of HCC through PTEN-AKT signaling.
    Zhou H; Du Y; Wei X; Song C; Song J; Xu N; Huang W; Chen L; Yao F; Du D; Qiu C; Zhong L; Liu Y; Gu D; Wang J; Xu Y
    Theranostics; 2022; 12(14):6069-6087. PubMed ID: 36168636
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.